GSK stock jumped Wednesday after the British drugmaker said it's "well positioned" to respond if the U.S. levies tariffs on ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

GSK PLC GSK shares advanced 3.60% to £14.84 Wednesday, on what proved to be an all-around favorable trading session for the ...

GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed yesterday ...

GSK (GSK) stock gains as the company's Q1 2025 results beat Street forecasts thanks to its Specialty Medicines business. Read ...

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The benchmark U.S. 10-year Treasury bond yield is near 4.5%. The yield was headed toward the key 5% threshold in April on hotter-than-expected inflation data, but turned lower after the May ...

Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

GlaxoSmithKline was formerly called GlaxoWelcome ... You can also buy U.K. stocks directly on the London Stock Exchange with an Interactive Brokers or Charles Schwab International brokerage ...

GSK has three segments ... For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover ...

GSK is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this Medical stock. GSK has a Momentum Style Score of A, and shares are up 2.9% over the past ...